BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
BACKGROUND
BRAF, KRAS and PIK3CA mutations are frequently found in sporadic colorectal cancer (CRC). In contrast to KRAS and PIK3CA mutations, BRAF mutations are associated with tumours harbouring CpG Island methylation phenotype (CIMP), MLH1 methylation and microsatellite instability (MSI). We aimed at determine the frequency of KRAS, BRAF and PIK3CA mutations in the process of colorectal tumourigenesis using a series of colorectal polyps and carcinomas. In the series of polyps CIMP, MLH1 methylation and MSI were also studied.


METHODS
Mutation analyses were performed by PCR/sequencing. Bisulfite treated DNA was used to study CIMP and MLH1 methylation. MSI was detected by pentaplex PCR and Genescan analysis of quasimonomorphic mononucleotide repeats. Chi Square test and Fisher's Exact test were used to perform association studies.


RESULTS
KRAS, PIK3CA or BRAF occur in 71% of polyps and were mutually exclusive. KRAS mutations occur in 35% of polyps. PIK3CA was found in one of the polyps. V600E BRAF mutations occur in 29% of cases, all of them classified as serrated adenoma. CIMP phenotype occurred in 25% of the polyps and all were mutated for BRAF. MLH1 methylation was not detected and all the polyps were microsatellite stable. The comparison between the frequency of oncogenic mutations in polyps and CRC (MSI and MSS) lead us to demonstrate that KRAS and PIK3CA are likely to precede both types of CRC. BRAF mutations are likely to precede MSI carcinomas since the frequency found in serrated polyps is similar to what is found in MSI CRC (P = 0.9112), but statistically different from what is found in microsatellite stable (MSS) tumours (P = 0.0191).


CONCLUSIONS
Our results show that BRAF, KRAS and PIK3CA mutations occur prior to malignant transformation demonstrating that these oncogenic alterations are primary genetic events in colorectal carcinogenesis. Further, we show that BRAF mutations occur in association with CIMP phenotype in colorectal serrated polyps and verified that colorectal serrated polyps and MSI CRC show a similar frequency of BRAF mutations. These results support that BRAF mutations harbour a mild oncogenic effect in comparison to KRAS and suggest that BRAF mutant colorectal cells need to accumulate extra epigenetic alterations in order to acquire full transformation and evolve to MSI CRC.
Velho
Sérgia
S
Institute of Molecular Pathology and Immunology, University of Porto, Portugal. svelho@ipatimup.pt
Moutinho
Cátia
C
Cirnes
Luís
L
Albuquerque
Cristina
C
Hamelin
Richard
R
Schmitt
Fernando
F
Carneiro
Fátima
F
Oliveira
Carla
C
Seruca
Raquel
R
D002277:Carcinoma / Q000378:metabolism; D058534:Class I Phosphatidylinositol 3-Kinases; D003111:Colonic Polyps / Q000235:genetics* / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000378:metabolism*; D019175:DNA Methylation; D004252:DNA Mutational Analysis; D015972:Gene Expression Regulation, Neoplastic; D011905:Genes, ras; D006801:Humans; D018895:Microsatellite Repeats; D008957:Models, Genetic; D009154:Mutation; D010641:Phenotype; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics* / Q000502:physiology*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics* / Q000502:physiology*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics* / Q000502:physiology*
D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D016283:Proto-Oncogene Proteins p21(ras)
Gut. 2004 Aug;53(8):1137-44
15247181
Cancer. 2005 Sep 1;104(5):952-61
16015629
Gut. 2004 Apr;53(4):573-80
15016754
Gut. 2002 Aug;51(2):200-6
12117880
Histopathology. 2007 Jan;50(1):113-30
17204026
Gastroenterology. 2005 Sep;129(3):837-45
16143123
J Pathol. 2007 Jun;212(2):124-33
17427169
Oncogene. 2003 Dec 11;22(57):9192-6
14668801
Hum Mol Genet. 2004 Oct 1;13(19):2303-11
15294875
Genes Dev. 2007 Feb 15;21(4):379-84
17299132
Eur J Cancer. 2005 Jul;41(11):1649-54
15994075
Nature. 1993 Jun 10;363(6429):558-61
8505985
Nat Genet. 2006 Jul;38(7):787-93
16804544
Oncogene. 2007 Jan 4;26(1):158-63
16953233
Nature. 2005 Aug 4;436(7051):720-4
16079850
Genes Chromosomes Cancer. 2004 Feb;39(2):138-42
14695993
Am J Surg Pathol. 2006 Dec;30(12):1491-501
17122504
Science. 2004 Apr 23;304(5670):554
15016963
N Engl J Med. 1988 Sep 1;319(9):525-32
2841597
Crit Rev Oncog. 2006 Dec;12(3-4):273-87
17425506
Cell. 2008 Feb 8;132(3):363-74
18267069
Gastroenterology. 2002 Dec;123(6):1804-11
12454837
Gastroenterol Clin North Am. 2007 Dec;36(4):947-68, viii
17996799
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18654-9
18003927